OPKO Health (NASDAQ: OPK) reported Q4 EPS of $0.01, $0.09 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $103.1 million versus the consensus estimate of $156.35 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.